StockData
Ascentage Pharma Group International logo

Ascentage Pharma Group International (AAPG) stock

AAPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 3/30
$13.14−0.15 (-1.13%)

Close on Nov 17, 2026Market cap $1.23BP/E –Yield –

Ascentage Pharma Group International r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was CN¥1.14B, up 20.1% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025CN¥1.14B+20.1%
FY2024Dec 31, 2024CN¥947.25M+34.0%
FY2023Dec 31, 2023CN¥706.97M-4.9%
FY2022Dec 31, 2022CN¥743.10M–

More Ascentage Pharma Group International figures

See a number that looks wrong?